The Cooper Companies, Inc.
$67.65
▲
0.52%
2026-04-22 10:12:13
www.coopercos.com
NMS: COO
Explore The Cooper Companies, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$13.23 B
Current Price
$67.65
52W High / Low
$89.83 / $61.78
Stock P/E
33.54
Book Value
$42.87
Dividend Yield
0.02%
ROCE
6.05%
ROE
4.87%
Face Value
—
EPS
$2.02
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
15,000
Beta
1.07
Debt / Equity
33.2
Current Ratio
1.34
Quick Ratio
1.13
Forward P/E
14.19
Price / Sales
3.35
Enterprise Value
$16.55 B
EV / EBITDA
15.05
EV / Revenue
3.98
Rating
Buy
Target Price
$91.07
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Strong operating margin profile.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | AtriCure, Inc. | $28.79 | — | $1.51 B | — | -1.65% | -2.4% | $43.18 / $27.26 | $9.88 |
| 2. | KORU Medical Systems, Inc. | $4.26 | — | $200.78 M | — | -14.86% | -15.58% | $6.61 / $2.08 | $0.37 |
| 3. | AngioDynamics, Inc. | $10.79 | — | $449.55 M | — | -11.8% | -17.47% | $13.99 / $8.36 | $4.16 |
| 4. | Jin Medical International Ltd. | $2.08 | 13.77 | $16.4 M | — | 2.06% | 4.75% | $19.7 / $1.64 | $3.79 |
| 5. | Precision Optics Corporation, Inc. | $4.44 | — | $47.43 M | — | -40.7% | -73.56% | $6.04 / $3.55 | $1.21 |
| 6. | West Pharmaceutical Services, Inc. | $274.81 | 40.51 | $19.81 B | 0.33% | 17.6% | 16.86% | $322.34 / $193.05 | $44.11 |
| 7. | Harvard Bioscience, Inc. | $6.99 | — | $30.92 M | — | 0.17% | -1.47% | $9.46 / $2.81 | $3.07 |
Quarterly Results
Figures shown in M / B
| Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | |
|---|---|---|---|---|---|
| Sales | 1.02 B | 1.07 B | 1.06 B | 1 B | 964.7 M |
| Operating Profit | 212.8 M | 140.4 M | 175.7 M | 184.8 M | 182 M |
| Net Profit | 130.8 M | 84.6 M | 98.3 M | 87.7 M | 104.3 M |
| EPS in Rs | 0.67 | 0.43 | 0.5 | 0.45 | 0.53 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 4.09 B | 3.9 B | 3.59 B | 3.31 B |
| Operating Profit | 682.9 M | 705.7 M | 533.1 M | 507.6 M |
| Net Profit | 374.9 M | 392.3 M | 294.2 M | 385.8 M |
| EPS in Rs | 1.92 | 2.01 | 1.51 | 1.98 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 12.39 B | 12.32 B | 11.66 B | 11.49 B |
| Total Liabilities | 4.16 B | 4.23 B | 4.11 B | 4.32 B |
| Equity | 8.24 B | 8.08 B | 7.55 B | 7.17 B |
| Current Assets | 2.11 B | 1.95 B | 1.7 B | 1.53 B |
| Current Liabilities | 1.11 B | 1.02 B | 969 M | 1.28 B |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 796.1 M | 709.3 M | 607.5 M | 692.4 M |
| Investing CF | -372.9 M | -764.6 M | -449 M | -1.83 B |
| Financing CF | -425.9 M | 39.2 M | -173.9 M | 1.19 B |
| Free CF | 433.7 M | 288.1 M | 215 M | 450.4 M |
| Capex | -362.4 M | -421.2 M | -392.5 M | -242 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 8.41% | 8.61% | — | — |
| Earnings Growth % | 33.34% | -23.74% | — | — |
| Profit Margin % | 10.07% | 8.19% | 11.66% | — |
| Operating Margin % | 18.12% | 14.84% | 15.34% | — |
| Gross Margin % | 66.64% | 65.62% | 64.67% | — |
| EBITDA Margin % | 27.51% | 24.65% | 26.56% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
| Ex Date | Dividend |
|---|---|
| 2023-07-26 | $0.0075 |
| 2023-01-20 | $0.0075 |
| 2022-07-26 | $0.0075 |
| 2022-01-20 | $0.0075 |
| 2021-07-26 | $0.0075 |
Stock Splits
| Date | Split |
|---|---|
| 2024-02-20 | 1:4 |